Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Total Liabilities: 2019-2025

Historic Total Liabilities for Benitec Biopharma (BNTC) over the last 6 years, with Mar 2025 value amounting to $7.6 million.

  • Benitec Biopharma's Total Liabilities rose 118.32% to $7.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $7.6 million, marking a year-over-year increase of 118.32%. This contributed to the annual value of $5.0 million for FY2024, which is 16.42% up from last year.
  • Latest data reveals that Benitec Biopharma reported Total Liabilities of $7.6 million as of Q1 2025, which was up 144.29% from $3.1 million recorded in Q4 2024.
  • Benitec Biopharma's Total Liabilities' 5-year high stood at $7.6 million during Q1 2025, with a 5-year trough of $1.4 million in Q2 2021.
  • In the last 3 years, Benitec Biopharma's Total Liabilities had a median value of $4.6 million in 2024 and averaged $4.7 million.
  • Per our database at Business Quant, Benitec Biopharma's Total Liabilities soared by 258.29% in 2021 and then slumped by 46.85% in 2024.
  • Quarterly analysis of 5 years shows Benitec Biopharma's Total Liabilities stood at $3.2 million in 2021, then fell by 8.40% to $2.9 million in 2022, then spiked by 102.10% to $5.9 million in 2023, then crashed by 46.85% to $3.1 million in 2024, then skyrocketed by 118.32% to $7.6 million in 2025.
  • Its Total Liabilities stands at $7.6 million for Q1 2025, versus $3.1 million for Q4 2024 and $4.6 million for Q3 2024.